Comparative study of Baralgan and hyoscine-N-methyl bromide in the treatment of intestinal and renal colicy pain.
D000293:Adolescent; D000328:Adult; D000632:Aminopyrine / Q000031:analogs & derivatives*; D001577:Benzophenones / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy*; D004177:Dipyrone / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D019832:N-Methylscopolamine; D010276:Parasympatholytics / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012602:Scopolamine Derivatives / Q000627:therapeutic use*
D001577:Benzophenones; D004338:Drug Combinations; D010276:Parasympatholytics; D010880:Piperidines; D012602:Scopolamine Derivatives; D000632:Aminopyrine; D004177:Dipyrone; C002416:fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination; D019832:N-Methylscopolamine